QuiaPEG Pharmaceuticals Holding AB (QUIA) — Strategic Asset Allocation Index
QuiaPEG Pharmaceuticals Holding AB (QUIA) has a Strategic Asset Allocation Index of 4.6% as of June 2023. Strategic assets (PP&E of Skr397.00K plus long-term investments of Skr-) total Skr397.00K, measured against net assets of Skr8.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check QuiaPEG Pharmaceuticals Holding AB (QUIA) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
QuiaPEG Pharmaceuticals Holding AB Strategic Asset Allocation Index (2018–2022)
This chart shows how QuiaPEG Pharmaceuticals Holding AB's Strategic Asset Allocation Index has evolved across 4 annual periods from 2018 to 2022. As of June 2023, the index stands at 4.6%, representing strategic assets of Skr397.00K against net assets of Skr8.71 Million SEK. See how financially flexible is QuiaPEG Pharmaceuticals Holding AB to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for QuiaPEG Pharmaceuticals Holding AB (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for QuiaPEG Pharmaceuticals Holding AB from 2018 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see QUIA market cap overview.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 21.7% | Skr524.00K | Skr524.00K | Skr- | Skr2.41 Million | ▼ -3514.6 pp |
| 2021 | 3536.4% | Skr778.00K | Skr778.00K | Skr- | Skr22.00K | ▲ +2216.6 pp |
| 2020 | 1319.7% | Skr937.00K | Skr937.00K | Skr- | Skr71.00K | ▲ +1292.6 pp |
| 2018 | 27.2% | Skr148.00K | Skr148.00K | Skr- | Skr545.00K | — |